GlobeNewswire Inc.··Researchandmarkets.ComAtopic Dermatitis Market to Triple to $21.5B by 2033, Driven by JAK Inhibitors
Atopic dermatitis drug market projected to grow from $8.5B (2023) to $21.5B (2033) at 9.8% CAGR, fueled by seven late-stage pipeline therapies.
PFEABBVLLYSNYREGNbiologicsatopic dermatitis